Patent details

Basic Information

Publication number:

EP2134873

PCT Application Number:

PCT/US/2008/058791

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP087446985

PCT Publication Number:

WO/2008/121899

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION

French Title of Invention:

PROCÉDÉ PERMETTANT DE PRÉDIRE UNE PRÉDISPOSITION À LA PROLONGATION DU QT

German Title of Invention:

VERFAHREN ZUR PROGNOSE EINER PRÄDISPOSITION FÜR QT-VERLÄNGERUNG

SPC Number:

Dates

Filing date:

28/03/2008

Grant date:

06/05/2015

EP Publication Date:

06/05/2015

PCT Publication Date:

09/10/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/12/2009

EP B1 Publication Date:

06/05/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/03/2016

Expiration date:

28/03/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/03/2008

 

 

Name:

Vanda Pharmaceuticals Inc.

Address:

2200 Pennsylvania Avenue Suite 300-E, Washington, DC 20037, United States (US)

Inventor

1

Name:

LAVEDAN Christian

Address:

United States (US)

2

Name:

VOLPI Simona

Address:

United States (US)

3

Name:

HEATON Callie, Michelle

Address:

United States (US)

4

Name:

MACK Kendra, Tomino

Address:

United States (US)

5

Name:

LICAMELE Louis

Address:

United States (US)

Priority

Priority Number:

908734 P

Priority Date:

29/03/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C12Q 1/68;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages